Vladislav Nodelman

Director, New Product Introduction Operations

Hologic, Inc.

Vladislav Nodelman is Director of New Product Introduction Operations at Hologic Inc. in San Diego. The NPI team leads the transfer of new diagnostic products from R&D into Operations with a vision of best-in-class product quality and optimized cost of goods through proactive, continuous implementation of risk-based design requirements and performance testing controls in product design, transfer, and manufacturing. Prior to Hologic, Dr. Nodelman developed injectable ophthalmic suspensions for treatment of macular degeneration at Pfizer and novel dry powder inhalers for treatment of respiratory disorders and management of diabetes at Dura Pharmaceuticals. 


Dr. Nodelman has multiple journal publications, patents, and over eighteen years of experience in industry with particular expertise in development, manufacturing, and post-launch support of FDA (CBER and CDRH) and EU regulated diagnostic products with >1 billion in revenue. Dr. Nodelman holds a B.S. in Bioengineering from the University of California at San Diego and a M.S. and Ph.D. in Bioengineering from the Pennsylvania State University.